CYCLERION THERAPEUTICS INC (CYCN) Stock Earnings & Estimates
USA - NASDAQ:CYCN - US23255M2044 - Common Stock
1.92 USD
-0.05 (-2.54%)
1.86 USD
-0.06 (-3.12%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 1.63M -58.63% | -100.00% | 2M | |
| EBITDA YoY % growth | -44.3M 17.72% | -9.647M 78.22% | N/A | |
| EBIT YoY % growth | -44.37M 18.30% | -9.647M 78.26% | -3.628M 62.39% | |
| Operating Margin | -2,722.09% | N/A | -181.40% | |
| EPS YoY % growth | N/A 96.01% | N/A -19.09% | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -42.86% | -0.41 | % | |
| Q3 2023 Q2Q % growth | -0.93 80.62% | -0.34 | -0.59 | -176.29% |
| Q2 2023 Q2Q % growth | 95.39% | -0.29 | % | |
| Q1 2023 Q2Q % growth | 95.07% | -0.30 | % | |
| Q4 2022 Q2Q % growth | 13.45% | -0.29 | % | |
| Q3 2022 Q2Q % growth | -4.80 -1,746.15% | -6.32 | 1.52 | 24.10% |
| Q2 2022 Q2Q % growth | -6.20 | -6.12 | -0.08 | -1.31% |
| Q1 2022 Q2Q % growth | -6.00 | -7.34 | 1.34 | 18.30% |
| Q4 2021 Q2Q % growth | -0.33 38.89% | -0.31 | -0.02 | -7.84% |
| Q3 2021 Q2Q % growth | -0.26 61.76% | -0.36 | 0.10 | 28.20% |
| Q4 2020 Q2Q % growth | -0.54 43.16% | -0.20 | -0.34 | -175.74% |
| Q3 2020 Q2Q % growth | -0.68 32.00% | -0.58 | -0.10 | -18.20% |
| Q2 2020 Q2Q % growth | -0.70 40.68% | -0.88 | 0.18 | 20.48% |
| Q1 2020 Q2Q % growth | -0.73 | -0.89 | 0.16 | 17.64% |
| Q4 2019 Q2Q % growth | -0.95 | -0.91 | -0.04 | -4.41% |
| Q3 2019 Q2Q % growth | -1.00 | -1.32 | 0.32 | 24.53% |
| Q2 2019 Q2Q % growth | -1.18 | -0.85 | -0.33 | -38.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q2 2023 Q2Q % growth | 100.00% | % | ||
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | 610K 15.09% | 610K | % | |
| Q3 2022 Q2Q % growth | -100.00% | 156.06K | -156.06K | -100.00% |
| Q2 2022 Q2Q % growth | -410K -113.67% | 362.61K | -772.61K | -213.07% |
| Q1 2022 Q2Q % growth | 710K 1,083.33% | 561K | 149K | 26.56% |
| Q4 2021 Q2Q % growth | 530K 307.69% | 918K | -388K | -42.27% |
| Q3 2021 Q2Q % growth | 350K -12.50% | 1.53M | -1.18M | -77.12% |
| Q2 2021 Q2Q % growth | 3M 300.00% | % | ||
| Q1 2021 Q2Q % growth | 60K -94.06% | % | ||
| Q4 2020 Q2Q % growth | 130K -91.22% | % | ||
| Q3 2020 Q2Q % growth | 400K -71.43% | % | ||
| Q2 2020 Q2Q % growth | 750K -53.99% | % | ||
| Q4 2019 Q2Q % growth | 1.48M | 483.48K | 996.52K | 206.11% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |